Actions of the pro-inflammatory cytokine IL-1β on central synaptic transmission

Experimental Physiology

Volumn 84, Issue 4, 1999, Pages 601-614

  O'Connor, John J ^a   Coogan, Andrew N ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM ION; GLUTAMIC ACID; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE;

BINDING AFFINITY; BRAIN; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; HIPPOCAMPUS; LONG TERM POTENTIATION; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0032802965     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0958067099018928     Document Type: Review

References (82)

1. ALLAN, S. M., LAWERENCE, C. B. & ROTHWELL, N. J. (1998). Interleukin-lβ and interleukin-1 receptor antagonist do not affect glutamate release or calcium entry in rat striatal synaptosomes. Molecular Psychiatry 3, 178-182.
2. ALESSI, D. R., CUENDA, A., COHEN, P., DUDLEY, D. T. & SALTIEL, A. R. (1995). PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. Journal of Biological Chemistry 270, 27489-27494.
3. BADIKG, H. & GREENBERG, M. E. (1991). Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science 253, 912-914.
4. BAN, E., MILON, G., PRUDHOM, N., PILLION, G. & HAOUR, F. (1991). Receptors for interleukin-1 (α and β) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43, 21-30.
5. BARON, C., BENES, B., VAN TAN, H., FAGARD, R. & ROISIN, M.-P. (1996). Potassium chloride pulse enhances MAP kinase activity in rat hippocampal slices. Journal ofNeurochemistry 66, 1005-1010.
6. BARROS, L. F., YOUNG, M., SAKLATVALA, J. & BALDWIN, S. A. (1997). Evidence for two mechanisms for the activation of the glucose transporter GLUT1 by anisomysin: p38 (MAP kinase) activation and protein synthesis inhibition in mammalian cells. Journal of Physiology 504, 517-525.
7. BELLINGER, F. P., MADAMBA, S. & SIGGINS, G. R. (1993). Interleukin-1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Research 628, 227-234.
8. BIRD, T. A., WOODWARD, A., JACKSON, J. L., DOWER, S. K. & SIMMS, J. E. (1991). Phorbol ester induces phosphorylation of the 80 kilodalton murine interleukin-1 receptor at a single theronine residue. Biochemical and Biophysical Research Communications 177, 61-67.
9. BLISS, T. V. P. & COLLINGTIDGE, G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-38.
10. BOULTON, T. G., NYE, S. H., ROBBINS, D. J., IP, N. Y., RADZIEJEWSKA, E., MORGENBESSER, S. D., DEPINHO, R. A., PANAYOTATOS, N., COBB, M. H. & YANCOPOULOS, G. D. (1991). ERKs: a family of protein-serine/threonine kinases that are activated and tryrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675.
11. iby interleukin-1β in rat cortical synatosomes. Involvement of a PTX-sensitive G-protein and p42 MAP kinase. NeuroReport 9, 9-12.
12. CAVUS, I. & TEYLER, T. (1996). Two forms of long-term potentiation in area CA1 activate different signal transduction cascades. Journal ofNeurophysiology 76, 3038-3047.
13. COOGAN, A. & O'CONNOR J. J. (1997). Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1β. NeuroReport 8, 2107-2110.
14. COOGAN, A. & O'CONNOR, J. J. (1999). Interleukin-1β inhibits a tetraethylammonium-induced synaptic potentiation in the rat dentate gyrus in vitro. European Journal of Pharmacology (in the Press).
15. COOGAN, A. N., O'LEARY, D. M. & O'CONNOR, J. J. (1999a). The P42/44 MAP kinase inhibitor PD98059 attenuates both NMDA-receptor dependent and independent forms of synaptic plasticity in the rat dentate gyrus in vitro. Journal ofNeurophysiology 81, 103-110.
16. COOGAN, A. N., O'NEILL, L. A. J. & O'CONNOR, J. J. (1999a). The p38 MAP kinase inhibitor SB203580 antagonises the inhibitory effect of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience (in the Press).
17. CUENDA, A., ROUSE, J., DOZA, Y. N., MEIER, R., COHEN, P., GALLAGHER, T. F., YOUNG, P. R. & LEE, J. C. (1995). SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1. FEES Letters 364, 229-233.
18. CUNNINGHAM, A. J., MURRAY, C. A., O'NEILL, L. A. J., LYNCH, M. A. & O'CONNOR, J. J. (1996). Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentaion in the rat dentate gyrus in vitro. Neuroscience Letters 203, 1-4.
19. CUNNINGHAM, E. T., WADA, E., CARTER, D. B., TRACEY, D. E., BATTERY, J. F. & DE SOUZA, E. B. (1992). In situ histochemical localization of type 1 interleukin-1 messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. Journal of Neuroscience 12, 1101-1114.
20. ENGLISH, J. D. & SWEATT, J. D. (1996). Activation of p42 MAPkinase in hippocampal LTP. Journal of Biological Chemistry 271, 24329-24332.
21. ENGLISH, J. D. & SWEATT, J. D. (1997). A requirement for the mitogen-activated protein kinase cascade in hippocampal long-term potentiation. Journal of Biological Chemistry 272, 19103-19106.
22. ERICSSON, A., Liu, C, HART, R. P. & SAWCHENKO, P. E. (1995). Type 1 interleukin-1 receptor in rat brain: distribution, regulation and relationship to sites of IL-1 induced cellular activation. Journal of Comparative Neurology 361, 681-698.
23. FAN, L., YOUNG, P. R., BARONE, F. C., FEUERSTEIN, G. Z., SMITH, D. H. & MCINTOSH, T. K. (1995). Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain. Molecular Brain Research 30, 125-130.
24. FUKANAGA, K. & MIYAMOTO, E. (1998). Role of MAP kinase in neurons. Molecular Neurobiology 16, 79-95.
25. HAOUR, F. G., BAN, E. M., MILON, G. M., BARAN, D. & PILLION, G. M. (1990). Brain interleukin-1 receptors: characterization and modulation after lipopolysaccharide injection. Progress in Neuroendrochronology 3, 196-204.
26. HIDAKA, H., WATANABE, M. & KOBAYASHI, R. (1991). Properties and use of H-series compounds as protein kinase inhibitors. Metabolic Enzymology 201, 328-336.
27. HOPKINS, S. J. & ROTHWELL, N. J. (1995). Cytokines and the nervous system I: expression and recognition. Trends in Neurosciences 18, 83-88.
28. KATUSKI, H., NAKAI, S., HIRAI, Y., AKAJI, K.-I., Kiso, Y. & SATOH, M. (1990). Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. European Journal of Pharmacology 181, 323-326.
29. KAWASAKI, H., MOROOKA, T., SHIMOHAMA, S., KIMURA, J., HIRANO, T., GOTOH, Y. & NISHIDA, E. (1997). Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. Journal of Biological Chemistry 272, 18518-18521.
30. KRAMER, R. M., ROBERTS, E. F., UM, S. L., BORSCH-HAUBOLD, A. G., WATSON, S. P., FISHER, M. J. & JAKUBOWSKI, J. A. (1996). p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin. Journal of Biological Chemistry 271, 27723-27729.
31. KURINO, M., FUKUNAGA, K., USHIO, Y. & MIYAMOTO, E. (1995). Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by Stimulation of glutamate receptors. Journal of Neurochemistry 65, 1282-1289.
32. KYRIAKIS, J. M. & AVRUCH, J. (1996). Sounding the alarm: protein kinase cascades activated by stress and inflammation. Journal of Biological Chemistry 21'1, 24313-24316.
33. LAWRENCE, C. B., ALLAN, S. M. & ROTHWELL, N. J. (1998). Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Journal of Neuroscience 10, 1188-1195.
34. LEE, J. C., LAYDEN, J. T., MCDONNELL, P. C., GALLAGHER, T. F., KUMAR, S., GREEN, D., MCNULTY, D., BLUMENTHAL, M. J., HEYS, J. R., LANDVATTER, S. W., STRICKLER, J. E., MCLAUGHLIN, M. M., SIEMENS, I. R., FISHER, S. M., LIVI, G. P., WHITE, J. R., ADAMS, J. L. & YOUNG, P. R. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
35. LIN, L.-L., WARTMAN, L., LIN, A. Y., KNOPF, J. L., SETH, A. & DAVIS, R. J. (1993). cPLA2 is phosphorylatcd and activated by MAP kinase. Cell 72, 269-278.
36. Liu, C., CHALMERS, D., MAKI, R. & DESOUZA, E. B. (1996). Rat homolog of mouse interleukin-1 receptor accessory protein: clonins, localization and modulation studies. Journal of Neuroimmitnology 66,41-48.
37. LODDICK, S. A., Liu, C., TAKAO, T., HASHIMOTO, K. & DESOUZA, E. B. (1998). Interleukin-1 receptors: cloning studies and a role in central nervous system disorders. Brain Research Reviews 26, 306-319.
38. LYNCH, M. A. (1998a). Analysis of the mechanisms underlying the age-related impairment of long-term potentiation in the rat. Reviews in Neuroscience 9, 169-201.
39. LYNCH, M. A. (1998fe). Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Progress in Neurobiology 56, 571-589.
40. MCDONALD, D. R., BAMBERGER, M. E., COMBS, C. K. & LANDRETH, G. E. (1998). β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in micoglia and THP1 monocytes. Journal ofNeuroscience 18,4451-4460.
41. MARONEY, A. C., GLICKSMAN, M. A., BASMA, A. N., WALTON, K. M., KNIGHT, E. JR, MURPHY, C. A., BARTLETT, B. A., FINN, J. P., ANGELES, T., MATSUDA, Y., NEFF, N. T. & DIONNE, C. A. (1998). Motorneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signalling pathway. Journal ofNeuroscience 18, 104-111.
42. MARUTA, E., YABUUCHI, K., NISHIYORI, A., TAKAMI, S., MINAMI, M. & SATOH, M. (1997). β2-Adrenoceptors on the glial cells mediate induction of interleukin-1β mRNA in the rat brain. Molecular Brain Research 49, 291-294.
43. MEDINA, J. H. & IZQUIERDO, I. (1995). Retrograde messengers, long-term potentiation and memory. Brain Research Reviews 21, 185-194.
44. MILLER, L. G. & FAHEY, J. M. (1994). Interleukin-1 modulates GABAergic and glutamatergic function in brain. Annals of the New York Academy of Sciences 279, 292-298.
45. Areceptor function in brain. Molecular Pharmacology 39, 105-108.
46. MURRAY, C. A. & LYNCH, M. A. (1998). Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation. Journal ofNeuroscience 18, 2974-2981.
47. MURRAY, C. A., MCGAHON, B., MCBENNET, S. & LYNCH, M. A. (1997). Interleukin-1β inhibits glutamate release in hippocampus of young, but not aged, rats. Neurobiology of Ageing 18, 343-348.
48. NGUYEN, P. V. & KANDEL, E. R. (1996). A macromolecular synthesis-dependent late phase of LTP requiring cAMP in the medial perforant pathway of rat hippocampal slice. Journal of Neiiroscience 16,3189-3198.
49. NISHIYORI, A., MINAMI, M., TAKAMI, S. & SATOH, M. (1997). Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. Molecular Brain Research 50, 237-245.
50. OITZL, M. S., VAN OERS, H., SCHOBITZ, B. & DEKLOET, E. R. (1993). Interleukin-1β, but not intcrleukin-6, impairs spatial navigation learning. Brain Research 613, 160-163.
51. OKAMURA, H., TSUTSI, H., KOMATSU, T., YUTSUDO, M., HAKURA, A., TANIMOTO, T., TORIGOE, K., OKURA, T., NUKADA, Y., HATTORI, K., AKITA, K., NAMBA, M., TANABE, F., KONISHI, K., FUKUDA, S. & KURIMOTO, M. (1995). Cloning of a new cytokine that induces IFN-gamma production by T-cells. Nature 378, 88-91.
52. O'NEILL, L. A. J. (1996). Pharmacological targets in the immune response. Interleukin-1 receptors and signal transduction. Biochemical Society Transactions 24, 207-211.
53. O'NEILL, L. A. J. (1997). Towards an understanding of the signal transduction pathway for interleukin-1. Biochimica et Biophysica Acta 1266, 31-44.
54. O'NEILL, L. A. J. & GREEN, C. (1998). Signal transduction pathways activated by the IL-1 receptor family: ancient signalling machinery in mammals, insects and plants. Journal of Leukocyte Biology 63, 650-657.
55. O'NEILL, L. A. J. & KALTSCHMIDT, C. (1997). NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends in Neiiroscience s 20, 252-258.
56. PANG, L., SAWADA, T., DECKERS, S. J. & SALTIEL, A. R. (1995). Inhibition of MAP kinase kinase blocks the difFercntiation of PC-12 cells induced by nerve growth factor. Journal of Biological Chemistry 270, 13585-13588.
57. PARNET, P., AMINDARI, S., Wu, C., BRUNKE-REESE, D., GOUJON, E., WEYHENMEYER, J. A., DANTZER, R. & KELLEY, K. W. (1994). Expression of type I and type II interlcukin-1 receptors in mouse brain. Molecular Brain Research 27, 63-70.
58. PEARSON, V., ROTHWELL, N. J. & TOULMOND, S. (1999). Excitotoxic brain damage in the rat induces IL-1 protein in microglia and astrocytes: correlation with the progression of cell death. Glia 25, 311-323.
59. PLATA-SALAMAN, C. R. & FFRENCH-MULLEN, J. M. H. (1992). Interleukin-1β depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Research Bulletin 29, 221-223.
60. 2+channel currents in hippocampal neurons through protein kinase C. Eitrpean Journal of Pharmacology 266, 1-10.
61. Aresponses by interleukin-1 (IL-1) through an indomethacin insensitive mechanism. Neuropharmacology 35, 147-152.
62. RAINGEAUD, J., GUPTA, S., ROGERS, J. S., DICKENS, M., HANS, J., ULEVITCH, R. J. & DAVIS, R. J. (1995). Pro-inflammatory cytokines and enviromental stress cause p38 mitogen-activated protein kinase activated by dual phosphorylation on tyrosine and threonine. Journal of Biological Chemistry 270, 7420-7426.
63. RELTON, J. K. & ROTHWELL, N. J. (1992). Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Research Bulletin 29, 243-246.
64. RIDELY, S. H., SARSFIELD, S. J., LEE, J. C., BIGG, H. R, CAWSTON, T. E., TAYLOR, D. J., DEWITT, D. L. & SAKLATVALA, J. (1997). Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase. Journal of Immunology 158, 3165-3173.
65. ROSEN, L. B., GINTY, D. D., WEDER, M. J. & GREENBERG, M. B. (1994). Membrane depolarization and calcium influx stimulate MEK and MAP kinsase via activation of ras. Neuron 12, 1207-1221.
66. ROTHWELL, N. (1999). Cytokines - killers in the brain. Journal of Physiology 514, 3-17.
67. ROTHWELL, N., ALLAN, S. & TOULMOND, S. (1997). The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. Journal of Clinical Investigation 100, 2648-2652.
68. ROTHWELL, N. J. & HOPKINS, S. J. (1995). Cytokines and the nervous system II: actions and mechanisms of action. Trends in Neurosciences 18, 130-136.
69. SAKLATVALA, J., DAVIS, W. & GUESDON, F. (1996). Interleukin l (IL1) and tumour necrosis factor (TNF) signal transduction. Philosophical Transactions of the Royal Society B 351, 151-157.
70. SCHNEIDER, H., PROSSI, F., BALSCHUN, D., WAGNER, A., DEL REY, A. & BESEDOVSKY, H. O. (1998). A neuromodulatory role of interleukin-1β in the hippocampus. Proceedings of the National Academy of Sciences of the USA 95, 7778-7783.
71. SEGER, R. & KREBS, E. G. (1996). The MAPK signalling cascade. FASED Journal 9, 726-735.
72. SIMS, J., GAYLE, M. A., SLACK, J. L., ALDERSON, M. R., BIRD, T. A., GIRI, J. G., COLOTTA, E., RE, F, MANTOVANI, A., SHANEBECK, K., GRABSTEIN, K. H. & DOWER, S. K. (1993). Interleukin-1 signalling occurs exclusively via the type 1 receptor. Proceedings of the National Academy of Sciences of the USA 90, 6155-6159.
73. TAKAO, T., TRACEY, D. E., MITCHELL, W. M. & DESOUZA, E. B. (1990). lnterleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 127, 3070-3078.
74. TRINGALI, G., Russo, D., PREZIOSI, P. & NAVARRA, P. (1998). Hypothalamic interleukin-1 in physiology and pathology. Toxicology Letters 102, 295-299.
75. WALTON, K. M., ENGBER, T. M., FINN, J. P., KOURY, E., CONTERAS, P. C., MILLER, M., DIONNE, C. A. & BHAT, R. V. (1997). MAPk is directed to diverse targets in brain. Society for Neuroscience Abstracts 23, 164.3.
76. WILK-BLASZCZAK, M., STEIN, B., Xu, S., BARBOSA, M. S., COBB, M. H. & BELARDETTI, F. (1998). The mitogen activated protein kinase p38-2 is necessary for the inhibition of N-type calcium current by bradykinin. Journal of Neuroscience 18, 112-118.
77. WONG, M. L. & LICINIO, J. (1994). Localization of interleukin-1 type I receptor mRNA in rat brain. Neiiroiinmunomodiilatlon 1, 110-115.
78. XIA, Z., DUDEK, H., MIRANTI, C. K. & GREENBERG, M. E. (1996). Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAPkinase/ERK-dependent mechanism. Journal of Neuroscience 16, 5425-5436.
79. Xu, X., RABER, J., YANG, D., Su, B. & MUCKE, L. (1997). Dynamic regulation of c-JUN N-terminal kinase activity in mouse brain by environmental stimuli. Proceedings of the National Academy of Sciences of the USA 94, 12655-12660.
80. Yu, B. & SHINNICK-GALLAGHER, P. (1994). Interleukin-1β inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons. Journal of Pharmacology and Experimental Therapeutics 211, 590-600.
81. ZEISE, M. L., ESPINOZA, J., MORALES, P. & NALLI, A. (1998). Interleukin-1β does not increase synaptic inhibition in hippocampal pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Research 768, 341-344.
82. ZEISE, M. L., MADAMBA, S. & SIGGINS, G. R. (1992). Interleukin-1β increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro. Regulatory Peptides 39, 1-7.